A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis

Veterinary Microbiology

Volumn 125, Issue 1-2, 2007, Pages 80-90

  Chockalingam, Annapoorani ^a   McKinney, Cindy E ^a   Rinaldi, Manuela ^b   Zarlenga, Dante S ^c   Bannerman, Douglas D ^c  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Bovine; Endotoxin; Escherichia coli; Lipopolysaccharide; Mastitis

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BACTERICIDAL PERMEABILITY INCREASING PROTEIN[148-161]; BACTERICIDAL PERMEABILITY INCREASING PROTEIN[90-99]; BACTERIUM LIPOPOLYSACCHARIDE; HYBRID PROTEIN; SYNTHETIC PEPTIDE; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBIOTIC THERAPY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CATTLE DISEASE; CONTROLLED STUDY; COW; ENTEROBACTER; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIDE SYNTHESIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CALCIUM; CATIONS, DIVALENT; CATTLE; EDETIC ACID; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; MAGNESIUM; MASTITIS, BOVINE; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; MILK; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS;

BACTERIA (MICROORGANISMS); BOS; BOVINAE; ENTEROBACTER; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS;

EID: 34548831343     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2007.05.004     Document Type: Article

References (41)

1. Abrahamson S.L., Wu H.M., Williams R.E., Der K., Ottah N., Little R., Gazzano-Santoro H., Theofan G., Bauer R., Leigh S., Orme A., Horwitz A.H., Carroll S.F., and Dedrick R.L. Biochemical characterization of recombinant fusions of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein Implications in biological activity. J. Biol. Chem. 272 (1997) 2149-2155
2. Anderson J.C., Burrows M.R., and Bramley A.J. Bacterial adherence in mastitis caused by Escherichia coli. Vet. Pathol. 14 (1977) 618-628
3. Bannerman D.D., Fitzpatrick M.J., Anderson D.Y., Bhattacharjee A.K., Novitsky T.J., Hasday J.D., Cross A.S., and Goldblum S.E. Endotoxin-neutralizing protein protects against endotoxin-induced endothelial barrier dysfunction. Infect. Immun. 66 (1998) 1400-1407
4. Bannerman D.D., Paape M.J., Lee J.W., Zhao X., Hope J.C., and Rainard P. Escherichia coli and Staphylococcus aureus elicit differential innate immune responses following intramammary infection. Clin. Diagn. Lab. Immunol. 11 (2004) 463-472
5. Beamer L. Human BPI: one protein's journey from laboratory into clinical trials. ASM News 68 (2002) 543-548
6. Beamer L.J., Carroll S.F., and Eisenberg D. The BPI/LBP family of proteins: a structural analysis of conserved regions. Protein Sci. 7 (1998) 906-914
7. Beckerdite S., Mooney C., Weiss J., Franson R., and Elsbach P. Early and discrete changes in permeability of Escherichia coli and certain other Gram-negative bacteria during killing by granulocytes. J. Exp. Med. 140 (1974) 396-409
8. Blondelle S.E., and Houghten R.A. Design of model amphipathic peptides having potent antimicrobial activities. Biochemistry (Moscow) 31 (1992) 12688-12694
9. Bogin E., and Ziv G. Enzymes and minerals in normal and mastitic milk. Cornell Vet. 63 (1973) 666-676
10. Bramley A.J. Variations in the susceptibility of lactating and non-lactating bovine udders to infection when infused with Escherichia coli. J. Dairy Res. 43 (1976) 205-211
11. Cooperstock M.S. Inactivation of endotoxin by polymyxin B. Antimicrob. Agents Chemother. 6 (1974) 422-425
12. El Zubeir I.E., ElOwni O.A., and Mohamed G.E. Effect of mastitis on macro-minerals of bovine milk and blood serum in Sudan. J. S. Afr. Vet. Assoc. 76 (2005) 22-25
13. Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J. Leukoc. Biol. 64 (1998) 14-18
14. Erskine R.J., Tyler J.W., Riddell Jr. M.G., and Wilson R.C. Theory, use, and realities of efficacy and food safety of antimicrobial treatment of acute coliform mastitis. J. Am. Vet. Med. Assoc. 198 (1991) 980-984
15. Fransson G.B., and Lonnerdal B. Distribution of trace elements and minerals in human and cow's milk. Pediatr. Res. 17 (1983) 912-915
16. Gaucheron F. The minerals of milk. Reprod. Nutr. Dev. 45 (2005) 473-483
17. Gazzano-Santoro H., Parent J.B., Grinna L., Horwitz A., Parsons T., Theofan G., Elsbach P., Weiss J., and Conlon P.J. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect. Immun. 60 (1992) 4754-4761
18. Gray B.H., and Haseman J.R. Bactericidal activity of synthetic peptides based on the structure of the 55-kilodalton bactericidal protein from human neutrophils. Infect. Immun. 62 (1994) 2732-2739
19. Jiang Z., Hong Z., Guo W., Xiaoyun G., Gengfa L., Yongning L., and Guangxia X. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo. Int. Immunopharmacol. 4 (2004) 527-537
20. Kelly C.J., Cech A.C., Argenteanu M., Gallagher H., Shou J., Minnard E., and Daly J.M. Role of bactericidal permeability-increasing protein in the treatment of Gram-negative pneumonia. Surgery 114 (1993) 140-146
21. Leong S.R., and Camerato T. Nucleotide sequence of the bovine bactericidal permeability increasing protein (BPI). Nucleic Acids Res. 18 (1990) 3052
22. Levin M., Quint P.A., Goldstein B., Barton P., Bradley J.S., Shemie S.D., Yeh T., Kim S.S., Cafaro D.P., Scannon P.J., and Giroir B.P. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 356 (2000) 961-967
23. Levy O., Sisson R.B., Kenyon J., Eichenwald E., Macone A.B., and Goldmann D. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of Gram-negative bacteria tested in neonatal cord blood ex vivo. Infect. Immun. 68 (2000) 5120-5125
24. Lin Y., Leach W.J., and Ammons W.S. Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit Gram-negative sepsis. Antimicrob. Agents Chemother. 40 (1996) 65-69
25. Little, R.G., 2002. Method for killing Gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein. U.S. Patent #6,495,516. United States Patent and Trademark Web Site: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6,495,516.PN.&OS=PN/6,495,516&RS=PN/6,495,516 (accessed on August 9, 2006).
26. Little R.G., Kelner D.N., Lim E., Burke D.J., and Conlon P.J. Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23). J. Biol. Chem. 269 (1994) 1865-1872
27. Martin M.J., Martin-Sosa S., Garcia-Pardo L.A., and Hueso P. Distribution of bovine milk sialoglycoconjugates during lactation. J. Dairy Sci. 84 (2001) 995-1000
28. Mather I.H., and Keenan T.W. Studies on the structure of milk fat globule membrane. J. Membr. Biol. 21 (1975) 65-85
29. McGregor, W.C., Stubstad, J., Chang, C.P., 1996. Pharmaceutical composition comprising BPI proteins. U.S. Patent #5,488,034. United States Patent and Trademark Web site: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=53&f=G&l=50&d=PTXT&s1=5488034&s2=bpi&co1=AND&p=2&OS=5488034+AND+bpi&RS=5488034+AND+bpi (accessed on March 28, 2007).
30. Miles A.A., and Maskell J.P. The neutralization of antibiotic action by metallic cations and iron chelators. J. Antimicrob. Chemother. 17 (1986) 481-487
31. Miles A.A., Maskell J.P., and Evans S.J. The quantification of the neutralization of the action of antibiotics by cationic iron. J. Antimicrob. Chemother. 18 (1986) 185-193
32. NCCLS. Methods for Determining Bacterial Activity of Antimicrobial Agents: Approved Guideline (1999), The National Committee for Clinical and Laboratory Standards (NCCLS), Wayne, PA p. 32
33. NCCLS. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals: Approved Standard. 2nd ed. (2002), The National Committee for Clinical Laboratory Standards (NCCLS), Wayne, PA p. 86
34. Neville M.C. Calcium secretion into milk. J. Mammary Gland Biol. Neoplasia 10 (2005) 119-128
35. Nicolas P., and Mor A. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 49 (1995) 277-304
36. Pazgier M., Prahl A., Hoover D.M., and Lubkowski J. Studies of the biological properties of human beta-defensin 1. J. Biol. Chem. 282 (2007) 1819-1829
37. Rogy M.A., Oldenburg H.S., Calvano S.E., Montegut W.J., Stackpole S.A., Van Zee K.J., Marra M.N., Scott R.W., Seilhammer J.J., Moldawer L.L., et al. The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock. J. Clin. Immunol. 14 (1994) 120-133
38. Russell A.D. Effect of magnesium ions and ethylenediamine tetra-acetic acid on the activity of vancomycin against Escherichia coli and Staphylococcus aureus. J. Appl. Bacteriol. 30 (1967) 395-401
39. Weiss J., Elsbach P., Olsson I., and Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J. Biol. Chem. 253 (1978) 2664-2672
40. Weiss J., Franson R.C., Beckerdite S., Schmeidler K., and Elsbach P. Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli. J. Clin. Invest. 55 (1975) 33-42
41. Ziv G. Treatment of peracute and acute mastitis. Vet. Clin. N. Am. Food Anim. Pract. 8 (1992) 1-15